GT Medical Technologies Recognizes New Excellence in GammaTile Treatment at Renown Regional Medical Center
GT Medical Technologies, a company committed to enhancing patient lives impacted by brain tumors, is thrilled to announce that Renown Regional Medical Center has received the distinguished GammaTile® Center of Excellence Program designation. This program honors institutions that exhibit exceptional leadership in the areas of patient education and clinical proficiency in administering the GammaTile procedure.
Renown Regional Medical Center joins a select group of healthcare providers recognized for their commitment to advancing innovative treatments for brain tumors. This designation is awarded to medical practitioners and their respective institutions who have shown remarkable expertise in executing the GammaTile procedure and have met stringent clinical criteria, including a set number of annual cases and ongoing education for their staff.
Among the notable physicians recognized under this esteemed program are Dr. Suchit Patel, a leading Radiation Oncologist, along with his colleagues: Dr. Garrett Green, Dr. Rima Rindler, Dr. Angelique Tay, Dr. Michael Moore, and Dr. Chris Demers, all specializing in various aspects of neurosurgery and radiation oncology. Dr. Patel expressed the significance of this achievement, stating, "This is a significant milestone for our team and for the patients we serve. Integrating advanced treatments like GammaTile allows us to push the boundaries of care for complex brain tumors, while ensuring our community can access state-of-the-art medicine right here, close to home."
What exactly is GammaTile? It is an innovative form of radiation therapy that is uniquely administered during the tumor removal surgery. This approach allows for direct and immediate delivery of targeted radiation right at the tumor site, which is particularly crucial when cancer cells are at their weakest. Traditionally, radiation therapy follows surgery only after wound healing has occurred, creating a gap in treatment that can risk tumor regrowth. In contrast, GammaTile enables immediate, localized radiation administration to enhance treatment effectiveness against remaining cancer cells, effectively reducing the likelihood of recurrence.
Founded by a passionate team of tumor specialists, GT Medical Technologies addresses the critical needs of patients suffering from brain tumors. Their commitment lies in continually improving patient outcomes by providing innovative solutions that redefine the standard of care. GammaTile is commercially authorized for use in the United States, offering a promising treatment option for newly diagnosed and recurrent malignant intracranial neoplasms.
The device itself is fascinating: GammaTile consists of a bioabsorbable collagen implant embedded with radiation seeds, designed for straightforward implantation during surgery. This ensures radiation is delivered at the surgical cavity to treat remaining cancer cells right from within during the most vulnerable phase.
Since its launch in March 2020, GammaTile has seen adoption in over 100 leading healthcare centers, marking its growing acceptance and integration into both academic and community healthcare settings. For further details on GammaTile and its benefits, visit gammatile.com and follow their updates across several social media platforms including Facebook, Instagram, LinkedIn, and X.
As brain tumor treatment continues to evolve with technological advancements, the designation of Renown Regional Medical Center as a GammaTile Center of Excellence symbolizes a promising future for patients in search of effective treatment options. GT Medical Technologies is dedicated to enhancing lives through medical innovation, illustrating how strategic partnerships between specialized medical teams and cutting-edge technologies can truly transform healthcare. For more information or inquiries, reach out to Dawn Fallon at New Dawn Communications.
Renown Regional Medical Center joins a select group of healthcare providers recognized for their commitment to advancing innovative treatments for brain tumors. This designation is awarded to medical practitioners and their respective institutions who have shown remarkable expertise in executing the GammaTile procedure and have met stringent clinical criteria, including a set number of annual cases and ongoing education for their staff.
Among the notable physicians recognized under this esteemed program are Dr. Suchit Patel, a leading Radiation Oncologist, along with his colleagues: Dr. Garrett Green, Dr. Rima Rindler, Dr. Angelique Tay, Dr. Michael Moore, and Dr. Chris Demers, all specializing in various aspects of neurosurgery and radiation oncology. Dr. Patel expressed the significance of this achievement, stating, "This is a significant milestone for our team and for the patients we serve. Integrating advanced treatments like GammaTile allows us to push the boundaries of care for complex brain tumors, while ensuring our community can access state-of-the-art medicine right here, close to home."
What exactly is GammaTile? It is an innovative form of radiation therapy that is uniquely administered during the tumor removal surgery. This approach allows for direct and immediate delivery of targeted radiation right at the tumor site, which is particularly crucial when cancer cells are at their weakest. Traditionally, radiation therapy follows surgery only after wound healing has occurred, creating a gap in treatment that can risk tumor regrowth. In contrast, GammaTile enables immediate, localized radiation administration to enhance treatment effectiveness against remaining cancer cells, effectively reducing the likelihood of recurrence.
Founded by a passionate team of tumor specialists, GT Medical Technologies addresses the critical needs of patients suffering from brain tumors. Their commitment lies in continually improving patient outcomes by providing innovative solutions that redefine the standard of care. GammaTile is commercially authorized for use in the United States, offering a promising treatment option for newly diagnosed and recurrent malignant intracranial neoplasms.
The device itself is fascinating: GammaTile consists of a bioabsorbable collagen implant embedded with radiation seeds, designed for straightforward implantation during surgery. This ensures radiation is delivered at the surgical cavity to treat remaining cancer cells right from within during the most vulnerable phase.
Since its launch in March 2020, GammaTile has seen adoption in over 100 leading healthcare centers, marking its growing acceptance and integration into both academic and community healthcare settings. For further details on GammaTile and its benefits, visit gammatile.com and follow their updates across several social media platforms including Facebook, Instagram, LinkedIn, and X.
As brain tumor treatment continues to evolve with technological advancements, the designation of Renown Regional Medical Center as a GammaTile Center of Excellence symbolizes a promising future for patients in search of effective treatment options. GT Medical Technologies is dedicated to enhancing lives through medical innovation, illustrating how strategic partnerships between specialized medical teams and cutting-edge technologies can truly transform healthcare. For more information or inquiries, reach out to Dawn Fallon at New Dawn Communications.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.